These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3918691)

  • 21. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
    Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
    J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
    Grunberg SM; Gala KV; Lampenfeld M; Jamin D; Johnson K; Cariffe P; Strych D; Krailo M
    J Clin Oncol; 1984 Jul; 2(7):782-7. PubMed ID: 6539812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis.
    Akhtar SS; Bano ZA; Bhat GM; Bhat MA
    Oncology; 1991; 48(3):226-9. PubMed ID: 2023702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
    Aasebø U; Slørdal L; Prytz PS; Aarbakke J
    Pharmacol Toxicol; 1987 May; 60(5):337-9. PubMed ID: 3303001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis].
    Dozono H; Ohmi K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):454-7. PubMed ID: 3954370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of cipropride in the treatment of digestive disorders induced by anticancer chemotherapy. Double-blind study using metoclopramide].
    Cristau P; Laverdant C; Coquelin JP; Narbonne G
    Med Chir Dig; 1981; 10(4):359-64. PubMed ID: 7029166
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
    Chiara S; Scarsi P; Campora E; Bruzzi P; Tatarek R; Rosso R
    Chemioterapia; 1984 Oct; 3(5):333-6. PubMed ID: 6398127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.
    Markham A; Sorkin EM
    Drugs; 1993 Jun; 45(6):931-952. PubMed ID: 7691500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metoclopramide therapy for chemotherapy -- induced nausea and vomiting.
    Paice JA
    Oncol Nurs Forum; 1983; 10(3):28-31. PubMed ID: 6553903
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
    Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
    J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.
    Marty M; Pouillart P; Scholl S; Droz JP; Azab M; Brion N; Pujade-Lauraine E; Paule B; Paes D; Bons J
    N Engl J Med; 1990 Mar; 322(12):816-21. PubMed ID: 2137902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The control of chemotherapy-induced nausea and vomiting].
    Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
    Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
    Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin].
    Culine S; Azab M; Pietri F; Ghosn M; Ben Amor B; Lupera H; Theodore C; Renaux J; Droz JP
    Bull Cancer; 1989; 76(6):583-9. PubMed ID: 2673437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of administration rate on cisplatin-induced emesis.
    Jordan NS; Schauer PK; Schauer A; Nightingale C; Golub G; Martin RS; Williams HM
    J Clin Oncol; 1985 Apr; 3(4):559-61. PubMed ID: 3884747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
    Cognetti F; Carlini P; Pinnarò P; Ruggeri EM; Caporali C
    Oncology; 1986; 43(5):292-4. PubMed ID: 3763123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
    J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.